Sandoz spin-off continues Novartis’ deal with innovation; $22bn buy rumoured

Novartis (Basel, Switzerland) has introduced plans for a spin-off of its underperforming subsidiary, Sandoz , and can deal with progressive therapy approaches for haematology, strong tumours, immunology, neuroscience and cardiovascular-related…

Novo Nordisk companions with Microsoft for AI-driven drug discovery

Novo Nordisk and Microsoft will undertake a platform technique to AI underneath the deal to coach a number of fashions for varied duties. Credit score: Novo Nordisk A/S. Novo Nordisk has signed a…

Amarin makes strikes in the direction of world enlargement of Vazkepa

Credit score: Getty photos/ ADAM GAULT/SPL Amarin goes full steam forward with its plans for world enlargement of its cardiovascular drug Vazkepa (Vascepa/icosapent ethyl). Free Report How is the Biopharmaceutical…

CMO Strikes: Regulatory catalysts for drug manufacturing-September

In current weeks, a number of regulatory selections on Covid-19 vaccines and boosters have come by way of which can be anticipated to spur vaccine manufacturing within the close to…

Merck’s HIV pipeline shifts as PrEP program discontinues

Credit: Shutterstock / nito Final week, Merck & Co introduced it’s discontinuing a program to review month-to-month oral doses of islatravir as pre-exposure prophylaxis (PrEP) remedy. This information got here…

Sanyou and KangaBio companion to advance growth of antibody drug

Sanyou and KangaBio will be part of forces to supply new prodrug growth for immunotherapy. Credit score: Rita Elena Serda, Duncan Complete Most cancers Heart at Baylor School of Drugs,…